Review: taking Crestor and Glumetza together


Summary

Drug interactions are reported among people who take Crestor and Glumetza together. This review analyzes the effectiveness and drug interactions between Crestor and Glumetza. It is created by eHealthMe based on reports of 6,911 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Crestor and Glumetza >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Crestor

Crestor has active ingredients of rosuvastatin calcium. It is often used in high blood cholesterol. (latest outcomes from Crestor 69,690 users)

Glumetza

Glumetza has active ingredients of metformin hydrochloride. It is often used in diabetes. (latest outcomes from Glumetza 414 users)

On Aug, 24, 2016

6,911 people who take Crestor, Glumetza are studied.


Number of reports submitted per year:

Crestor and Glumetza drug interactions.

Drug effectiveness over time:

Crestor:
  • < 1 month: 0.0% - (0 of 3 people)
  • 1 - 6 months: 23.0% - (6 of 26 people)
  • 6 - 12 months: 55.0% - (11 of 20 people)
  • 1 - 2 years: 60.0% - (25 of 41 people)
  • 2 - 5 years: 69.0% - (50 of 72 people)
  • 5 - 10 years: 59.0% - (26 of 44 people)
  • 10+ years: 85.0% - (6 of 7 people)
  • not specified: 100.0% - (1 of 1 people)
Glumetza:
  • < 1 month: 44.0% - (4 of 9 people)
  • 1 - 6 months: 8.0% - (2 of 24 people)
  • 6 - 12 months: 38.0% - (5 of 13 people)
  • 1 - 2 years: 35.0% - (17 of 48 people)
  • 2 - 5 years: 40.0% - (26 of 65 people)
  • 5 - 10 years: 45.0% - (20 of 44 people)
  • 10+ years: 34.0% - (9 of 26 people)
  • not specified: 0.0% - (0 of 1 people)

Drug effectiveness by gender:

Crestor:
  • female: 61.0% - (59 of 96 people)
  • male: 55.0% - (66 of 118 people)
Glumetza:
  • female: 42.0% - (46 of 107 people)
  • male: 30.0% - (37 of 123 people)

Drug effectiveness by age:

Crestor:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 4 people)
  • 40-49: 48.0% - (21 of 43 people)
  • 50-59: 65.0% - (51 of 78 people)
  • 60+: 59.0% - (53 of 89 people)
Glumetza:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 12.0% - (1 of 8 people)
  • 40-49: 35.0% - (17 of 48 people)
  • 50-59: 37.0% - (31 of 82 people)
  • 60+: 36.0% - (34 of 92 people)

Most common drug interactions over time *:

< 1 month:
  • myalgia
  • renal failure acute
  • headache
  • dyspnoea
  • feeling abnormal
  • muscle spasms
  • arthralgia
  • fatigue
  • rhabdomyolysis
  • diabetes mellitus
1 - 6 months:
  • myalgia
  • dizziness
  • nausea
  • rhabdomyolysis
  • blood creatine phosphokinase increased
  • optic neuritis
  • diabetes mellitus
  • blood cholesterol increased
  • vomiting
  • alanine aminotransferase increased
6 - 12 months:
  • liver injury
  • myalgia
  • pain in extremity
  • abdominal pain
  • dizziness
  • fatigue
  • nausea
  • vomiting
  • headache
  • cytolytic hepatitis
1 - 2 years:
  • myalgia
  • liver injury
  • high density lipoprotein decreased
  • fatigue
  • leukocytoclastic vasculitis
  • elevated mood
  • dizziness
  • gamma-glutamyltransferase increased
  • myocardial infarction
  • headache
2 - 5 years:
  • chest pain
  • dizziness
  • memory impairment
  • myocardial infarction
  • fatigue
  • muscle spasms
  • renal failure acute
  • alopecia
  • thrombocytopenia
  • weight decreased
5 - 10 years:
  • hypoglycaemia
  • lactic acidosis
  • renal failure acute
  • cardiac failure congestive
  • hepatic failure
  • myocardial ischaemia
  • thrombocytopenia
  • malignant neoplasm progression
  • myocardial infarction
  • ascites
10+ years:
  • erectile dysfunction
  • impotence
  • intracranial pressure increased
  • migraine
  • pulmonary hypertension
  • abdominal pain upper
  • anxiety
  • diabetes
  • diarrhea associated with medications
  • dizziness
not specified:
  • nausea
  • blood glucose increased
  • dyspnoea
  • fatigue
  • weight decreased
  • pain
  • diarrhoea
  • pain in extremity
  • renal failure acute
  • dizziness

Most common drug interactions by gender *:

female:
  • nausea
  • myalgia
  • pain
  • weight decreased
  • pain in extremity
  • diarrhoea
  • blood glucose increased
  • fatigue
  • dyspnoea
  • fall
male:
  • blood glucose increased
  • nausea
  • fatigue
  • dyspnoea
  • myocardial infarction
  • weight decreased
  • flushing
  • renal failure acute
  • headache
  • malaise

Most common drug interactions by age *:

0-1:
  • abdominal pain
  • cytolytic hepatitis
  • diffuse alveolar damage
  • ejaculation failure
  • myalgia
  • abasia
  • anomaly of external ear congenital
  • asthenia
  • autoimmune hepatitis
  • blood cholesterol increased
2-9:
  • adrenal mass
  • diabetes mellitus inadequate control
  • disorientation
  • erythema multiforme
  • foot fracture
  • hyperlipidaemia
  • hypertension
  • hypothyroidism
  • joint swelling
  • musculoskeletal pain
10-19:
  • drug ineffective
  • nausea
  • type 2 diabetes mellitus
  • abdominal pain upper
  • blood cholesterol increased
  • ear infection
  • gastrooesophageal reflux disease
  • pharyngitis
  • menstruation irregular
  • sleep apnoea syndrome
20-29:
  • dizziness
  • diabetes mellitus
  • fatigue
  • cholecystitis chronic
  • chest pain
  • dyspnoea
  • gait disturbance
  • hypotension
  • injury
  • pain
30-39:
  • type 2 diabetes mellitus
  • weight decreased
  • fatigue
  • pain
  • malaise
  • gastrooesophageal reflux disease
  • convulsion
  • sinus tachycardia
  • injury
  • muscle spasms
40-49:
  • nausea
  • diarrhoea
  • pain
  • chest pain
  • diabetes mellitus
  • myocardial infarction
  • arthralgia
  • blood glucose increased
  • dizziness
  • dyspnoea
50-59:
  • nausea
  • blood glucose increased
  • renal failure acute
  • myocardial infarction
  • weight decreased
  • fatigue
  • headache
  • weight increased
  • myalgia
  • vomiting
60+:
  • dyspnoea
  • blood glucose increased
  • nausea
  • renal failure acute
  • fatigue
  • asthenia
  • myalgia
  • weight decreased
  • diarrhoea
  • dizziness

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Crestor and Glumetza?

Can you answer these questions?

More questions for: Crestor, Glumetza

You may be interested in these reviews

More reviews for: Crestor, Glumetza

On eHealthMe, Crestor (rosuvastatin calcium) is often used to treat high blood cholesterol. Glumetza (metformin hydrochloride) is often used to treat diabetes. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.